Hemoccult II SENSA Dispensapak Plus


(40 Patient Screening Kits, 2 Bottles 15mL Developer)

The Hemoccult II SENSA test is a rapid, convenient and qualitative method for detecting fecal occult blood which may be indicative of gastrointestinal disease. It is not a test for colorectal cancer or any other specific disease. Hemoccult II SENSA is the enhanced Hemoccult product that provides improved readability and higher clinical sensitivity over regular Hemoccult and other FOBTs.
FDA Cleared and CLIA waived
(FDA 510K#: K880499)

Hemoccult and Hemoccult II are registered trademarks of Beckman Coulter, Inc. SENSA is a registered trademark of SmithKline Diagnostics, Inc.

  • Improved readability, intense blue reaction
  • Higher clinical sensitivity
  • Detection of more true positives
  • 14-day on-slide stability
  • Used in colorectal cancer screening programs worldwide
  • Comprehensive patient educational support
  • CLIA Category
    • CLIA-waived

Hemoccult II SENSA Slides are designed so patients can collect serial specimens at home from bowel movements over 3 days. After the patient prepares the Hemoccult II SENSA test, it may be returned in person or by mail (using the Hemoccult Mailing Pouch) to the laboratory, hospital or medical office for developing and interpretation.

Hemoccult SENSA Single Slides are convenient for use when single fecal specimens are collected for routine in-office gastrointestinal screening.

© 2020 Cliawaived, Inc. All Rights Reserved. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them.